Levosimendan improved recovery and hemodynamics versus IABP in high-risk CABG patients but showed a non-significant increase in mediastinitis risk.
Does Levosimendan improve recovery and hemodynamic outcomes in high-risk CABG patients compared to Intra-Aortic Balloon Pump?
In high-risk CABG patients, levosimendan may improve recovery and hemodynamics compared to IABP, though it may carry a non-significant risk of mediastinitis.
Absolute Event Rate: 0% vs 0%
Levosimendan may improve recovery and hemodynamic outcomes in high-risk CABG patients compared to IABP but may be associated with a higher, though non-significant, risk of mediastinitis. Further high-quality studies are warranted.
Han et al. (Fri,) reported a other. Levosimendan improved recovery and hemodynamics versus IABP in high-risk CABG patients but showed a non-significant increase in mediastinitis risk.